BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1979082)

  • 1. Overview of the International Conference on Particle Detection, Metrology, and Control.
    Knapp JZ; Barber TA
    J Parenter Sci Technol; 1990; 44(5):257-63. PubMed ID: 1979082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to papers on mycoplasmology presented at a Parenteral Drug Association mycoplasma workshop.
    Potts BJ
    Biologicals; 2010 Mar; 38(2):181-2. PubMed ID: 20079662
    [No Abstract]   [Full Text] [Related]  

  • 3. A new coincidence model for single particle counters, Part II: Advances and applications.
    Knapp JZ; Lieberman A; Abramson LR
    PDA J Pharm Sci Technol; 1994; 48(5):255-92. PubMed ID: 8000900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 5. Current good manufacturing practice: proposed revision of certain requirements for finished pharmaceuticals; proposed rule, May 3, 1996 (61 FR 20103), [Docket No. 95N-0362]. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1996; 50(6):346-51. PubMed ID: 9038078
    [No Abstract]   [Full Text] [Related]  

  • 6. Subvisible Particulate Contamination in Cell Therapy Products-Can We Distinguish?
    Vollrath I; Mathaes R; Sediq AS; Jere D; Jörg S; Huwyler J; Mahler HC
    J Pharm Sci; 2020 Jan; 109(1):216-219. PubMed ID: 31521641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the International Conference on Liquid Borne Particle Inspection and Metrology.
    Barber TA; Borchert SJ; Carleton FJ; Knapp JZ
    J Parenter Sci Technol; 1987; 41(6):193-7. PubMed ID: 3437368
    [No Abstract]   [Full Text] [Related]  

  • 8. Particulate matter determination in LVPs produced in Dutch hospital pharmacies, Part 1: Particle-counting accuracy.
    Van der Veen J; Verbrugge P; Van de Vaart FJ; Boom FA
    PDA J Pharm Sci Technol; 1997; 51(2):81-8. PubMed ID: 9146039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An approach to setting particulate matter standards for small volume parenterals.
    DeLuca PP; Boddapati S; Haack D; Schroeder H
    J Parenter Sci Technol; 1986; 40(1):2-13. PubMed ID: 3701538
    [No Abstract]   [Full Text] [Related]  

  • 10. The scientific basis for visible particle inspection.
    Knapp JZ
    PDA J Pharm Sci Technol; 1999; 53(6):291-302. PubMed ID: 10754727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Particulate Matter in Liquid-Finished Dosage Forms.
    Duchek J; Havasi B
    PDA J Pharm Sci Technol; 2018; 72(6):608-625. PubMed ID: 29853612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to reducing subvisible particle counts in lyophilized parenteral formulations.
    Gupta PK; Porembski E; Williams NA
    J Pharm Sci Technol; 1994; 48(1):30-7. PubMed ID: 8004415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic particle counters used for regulatory monitoring of particulates in LVPs: statistical analysis.
    Oxborrow GS; Nierman ML; Heisick JE; Lanier JM
    J Parenter Sci Technol; 1981; 35(5):237-41. PubMed ID: 7299600
    [No Abstract]   [Full Text] [Related]  

  • 14. Industry perspective on the medical risk of visible particles in injectable drug products.
    Bukofzer S; Ayres J; Chavez A; Devera M; Miller J; Ross D; Shabushnig J; Vargo S; Watson H; Watson R
    PDA J Pharm Sci Technol; 2015; 69(1):123-39. PubMed ID: 25691720
    [No Abstract]   [Full Text] [Related]  

  • 15. GMP and quality trends in Europe.
    Sharp J
    J Parenter Sci Technol; 1990; 44(6):296-9. PubMed ID: 2277315
    [No Abstract]   [Full Text] [Related]  

  • 16. Hygienic standard of parenteral solutions.
    Winding O
    Ugeskr Laeger; 1977 Dec; 139(49):2940-4. PubMed ID: 595183
    [No Abstract]   [Full Text] [Related]  

  • 17. [New cleanliness assessement for particulate matters in large-volume parenteral injection].
    Tsuji S; Isaka H
    Yakugaku Zasshi; 1987 Mar; 107(3):238-44. PubMed ID: 3598875
    [No Abstract]   [Full Text] [Related]  

  • 18. Aseptic processing contamination case studies and the pharmaceutical quality system.
    Friedman RL
    PDA J Pharm Sci Technol; 2005; 59(2):118-26. PubMed ID: 15971544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative sum control charts for admixture quality control.
    Sanford RL
    Am J Hosp Pharm; 1980 May; 37(5):655-9. PubMed ID: 7386472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameter for assessing parenteral cleanliness based on particle-size distributions.
    Blanchard J; Schwartz JA; Byrne DM
    J Pharm Sci; 1977 Aug; 66(8):1083-6. PubMed ID: 894493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.